918523-63-4 Usage
Uses
Used in Pharmaceutical Industry:
1H-Pyrrolo[2,3-b]pyridine-5-methanol, a,a-dimethyl-1-[tris(1-methylethyl)silyl]is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with unique therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 1H-Pyrrolo[2,3-b]pyridine-5-methanol, a,a-dimethyl-1-[tris(1-methylethyl)silyl]is utilized as a precursor in the production of agrochemicals, potentially enhancing crop protection and yield through novel chemical entities.
Used in Material Science:
1H-Pyrrolo[2,3-b]pyridine-5-methanol, a,a-dimethyl-1-[tris(1-methylethyl)silyl]is employed in material science as a component in the development of new materials, leveraging its structural and reactive features to create materials with specific properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 918523-63-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,5,2 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 918523-63:
(8*9)+(7*1)+(6*8)+(5*5)+(4*2)+(3*3)+(2*6)+(1*3)=184
184 % 10 = 4
So 918523-63-4 is a valid CAS Registry Number.
InChI:InChI=1/C19H32N2OSi/c1-13(2)23(14(3)4,15(5)6)21-10-9-16-11-17(19(7,8)22)12-20-18(16)21/h9-15,22H,1-8H3
918523-63-4Relevant academic research and scientific papers
COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
-
Page/Page column 36, (2008/12/06)
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
PYRROLO[2,3-B] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 113-114, (2010/11/25)
Compounds of formula III which are active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
